Live Updates: COVID-19 Cases
  • World 21,128,511
    World
    Confirmed: 21,128,511
    Active: 6,396,965
    Recovered: 13,973,224
    Death: 758,322
  • USA 5,418,071
    USA
    Confirmed: 5,418,071
    Active: 2,403,363
    Recovered: 2,844,262
    Death: 170,446
  • Brazil 3,229,621
    Brazil
    Confirmed: 3,229,621
    Active: 767,417
    Recovered: 2,356,640
    Death: 105,564
  • India 2,483,567
    India
    Confirmed: 2,483,567
    Active: 664,518
    Recovered: 1,770,682
    Death: 48,367
  • Russia 912,823
    Russia
    Confirmed: 912,823
    Active: 174,361
    Recovered: 722,964
    Death: 15,498
  • South Africa 572,865
    South Africa
    Confirmed: 572,865
    Active: 123,978
    Recovered: 437,617
    Death: 11,270
  • Peru 507,996
    Peru
    Confirmed: 507,996
    Active: 134,342
    Recovered: 348,006
    Death: 25,648
  • Mexico 505,751
    Mexico
    Confirmed: 505,751
    Active: 108,951
    Recovered: 341,507
    Death: 55,293
  • Chile 380,034
    Chile
    Confirmed: 380,034
    Active: 16,604
    Recovered: 353,131
    Death: 10,299
  • Spain 355,856
    Spain
    Confirmed: 355,856
    Active: 327,251
    Recovered: ?
    Death: 28,605
  • Iran 338,825
    Iran
    Confirmed: 338,825
    Active: 25,683
    Recovered: 293,811
    Death: 19,331
  • UK 313,798
    UK
    Confirmed: 313,798
    Active: 272,451
    Recovered: ?
    Death: 41,347
  • Saudi Arabia 295,902
    Saudi Arabia
    Confirmed: 295,902
    Active: 29,605
    Recovered: 262,959
    Death: 3,338
  • Pakistan 287,300
    Pakistan
    Confirmed: 287,300
    Active: 15,932
    Recovered: 265,215
    Death: 6,153
  • Bangladesh 271,881
    Bangladesh
    Confirmed: 271,881
    Active: 111,667
    Recovered: 156,623
    Death: 3,591
  • Italy 252,235
    Italy
    Confirmed: 252,235
    Active: 14,081
    Recovered: 202,923
    Death: 35,231
  • Turkey 245,635
    Turkey
    Confirmed: 245,635
    Active: 11,666
    Recovered: 228,057
    Death: 5,912
  • Germany 222,487
    Germany
    Confirmed: 222,487
    Active: 12,404
    Recovered: 200,800
    Death: 9,283
  • France 209,365
    France
    Confirmed: 209,365
    Active: 95,505
    Recovered: 83,472
    Death: 30,388
  • Canada 121,234
    Canada
    Confirmed: 121,234
    Active: 4,666
    Recovered: 107,553
    Death: 9,015
  • China 84,786
    China
    Confirmed: 84,786
    Active: 690
    Recovered: 79,462
    Death: 4,634
  • Netherlands 61,840
    Netherlands
    Confirmed: 61,840
    Active: 55,673
    Recovered: ?
    Death: 6,167
  • Australia 22,743
    Australia
    Confirmed: 22,743
    Active: 9,018
    Recovered: 13,350
    Death: 375
  • S. Korea 14,873
    S. Korea
    Confirmed: 14,873
    Active: 705
    Recovered: 13,863
    Death: 305
  • New Zealand 1,602
    New Zealand
    Confirmed: 1,602
    Active: 49
    Recovered: 1,531
    Death: 22

Non-invasive techniques developed to check neonatal bilirubin level

Author at TechGenyz Science
Bilirubin
A Photograph Represents Bilirubin. Credit: @PranayaApp/Twitter

Scientists at the SN Bose National Centre for Basic Sciences, Kolkata, have developed non-contact and non-invasive spectrometry-based techniques for measurement of bilirubin level in newborns to screen for signs of jaundice, an official statement said on Wednesday.

The device through which the techniques are carried out is called AJO-Neo and has been developed by Prof. Samir K. Pal and his group at SNBNCBS, an autonomous research institute under the Department of Science and Technology (DST).

The operation of the device is based on non-contact and non-invasive spectrometry-based techniques for measurement of neonatal bilirubin level as an alternative of total serum bilirubin (TSB) test without limitations of other available bilirubin meters.

Careful screening of bilirubin level in newborns is mandatory as per the American Academy of Paediatrics (2004) to reduce incidents of a type of brain damage called kernicterus that can result from high levels of bilirubin in a baby’s blood.

Although invasive capillary collection of blood and the subsequent biochemical test is considered a gold standard for jaundice detection in neonates, transcutaneous bilirubin measurement using non-invasive instruments has obvious added advantages, the statement said.

The SNBNCS is also hosting one of the Technical Research Centres (TRC) funded by DST and in scientific collaboration with Nil-Ratan Sircar (NRS) Medical College and Hospital, Kolkata.

According to the study conducted by the SNBNCBS team in NRS medical college, the newly developed device (AJO-Neo) is reliable in measuring bilirubin levels in preterm, and term neonates irrespective of gestational or postnatal age, sex, risk factors, feeding behavior or skin color.

The device is found to deliver an almost instantaneous report (about 10 seconds) to the doctor concerned irrespective of the location he is.

This is a significant achievement compared to the conventional blood test method, which may take more than 4 hours to generate the report, the statement added.

The detection of neonatal blood bilirubin (Hyperbilirubinemia) faster is extremely important for therapeutic management in order to avoid kernicterus leading to neuo-psychiatry problems in neonatal subjects, the statement said.

AJO-Neo also shows several advantages compared to other similar imported devices in the market, the statement added.

Development of convenient, non-invasive diagnostics based on deep understanding of physicochemical sciences is happening at a faster pace around the world, and the institutions focused on basic sciences such as SN Bose National Centre For Basic Sciences at Kolkata, are thus compelling partners in technology and device development, said Prof Ashutosh Sharma, Secretary, DST.

The Technology has been transferred by the National Research Development Corporation (NRDC), a PSU under the Department of Scientific and Industrial Research to a Vijayawada based company, M/s Zyna Medtech Private Limited.

Career

Subscribe